A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor.
Phase of Trial: Phase III
Latest Information Update: 26 Aug 2014
At a glance
- Drugs Dapoxetine (Primary)
- Indications Premature ejaculation
- Focus Registrational; Therapeutic Use
- Acronyms COUPLE
- Sponsors Janssen Research & Development
- 12 Jan 2012 Actual patient number is 495 according to ClinicalTrials.gov.
- 12 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jul 2011 Planned end date changed from Jan 2012 to Sep 2011 as reported by ClinicalTrials.gov.